ijms-logo

Journal Browser

Journal Browser

Nano Based Drug Delivery Systems: Future and Development

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Materials Science".

Deadline for manuscript submissions: closed (31 May 2023) | Viewed by 1833

Special Issue Editor


E-Mail Website
Guest Editor
Department of Chemistry, University of Melbourne, Parkville, VIC 3010, Australia
Interests: stimuli-responsive nanoparticles; drug delivery; endosomal escape
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Drugs are a mainstay of modern medicine, but drug development must overcome many hurdles. Nanoparticle technology offers a method to improve therapeutic efficacy by protecting drug cargo and delivering it with high selectivity to a target site. This is particularly important in the field of biological therapeutics including DNA and RNA, which degrade rapidly if delivered in isolation. Although there have been some successes with nanoparticle delivery of biological cargo such as in the recent COVID vaccines, and the siRNA therapy Patisiran, there are still serious issues with efficient delivery of these therapeutics. These include targeting of specific cells, internalization, endosomal escape as well as release of the cargo and intracellular trafficking to site of action. In this Special Issue we will focus on understanding how nanoparticles can be engineered to better migrate these biological barriers and thus provide more efficient delivery systems in the future. Some relevant topics include:

  • Stimuli responsive nanoparticles;
  • Controlling loading and release of biological cargo;
  • Understanding impact of targeting, internalisation, endosomal escape or intracellular trafficking on therapeutic activity;
  • New techniques to study nanoparticle/biological interactions.

Dr. Georgina Such
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • stimuli-responsive nanoparticles
  • endosomal escape
  • delivery
  • nucleic acid

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

16 pages, 2619 KiB  
Article
Assessment of Efficacy and Safety Using PPAR-γ Agonist-Loaded Nanocarriers for Inflammatory Eye Diseases
by Esther Miralles, Christina S. Kamma-Lorger, Òscar Domènech, Lilian Sosa, Isidre Casals, Ana Cristina Calpena and Marcelle Silva-Abreu
Int. J. Mol. Sci. 2022, 23(19), 11184; https://doi.org/10.3390/ijms231911184 - 23 Sep 2022
Cited by 1 | Viewed by 1504
Abstract
Drug-loaded nanocarriers (NCs) are new systems that can greatly improve the delivery and targeting of drugs to specific tissues and organs. In our work, a PPAR-γ agonist loaded into polymeric NCs was prepared, stabilized by spray-drying, and tested in vitro, ex vivo, and [...] Read more.
Drug-loaded nanocarriers (NCs) are new systems that can greatly improve the delivery and targeting of drugs to specific tissues and organs. In our work, a PPAR-γ agonist loaded into polymeric NCs was prepared, stabilized by spray-drying, and tested in vitro, ex vivo, and in vivo (animal models) to provide a safe formulation for optical anti-inflammatory treatments. The NCs were shown to be well tolerated, and no signs of irritancy or alterations of the eye properties were detected by the in vitro HET-CAM test and in vivo Draize test. Furthermore, no signs of cytotoxicity were found in the NC formulations on retinoblastoma cells (Y-79) analyzed using the alamarBlue assay, and the transmittance experiments evidenced good corneal transparency with the formulations tested. The ocular anti-inflammatory study confirmed the significant prevention efficacy using the NCs, and these systems did not affect the corneal tissue structure. Moreover, the animal corneal structure treated with the NCs was analyzed using X-ray diffraction using synchrotron light. Small-angle X-ray scattering (SAXS) analysis did not show a significant difference in corneal collagen interfibrillar spacing after the treatment with freshly prepared NCs or NCs after the drying process compared to the corresponding negative control when inflammation was induced. Considering these results, the PPAR-γ agonist NCs could be a safe and effective alternative for the treatment of inflammatory ocular processes. Full article
(This article belongs to the Special Issue Nano Based Drug Delivery Systems: Future and Development)
Show Figures

Figure 1

Back to TopTop